| Document |
Document Title |
|
WO/2007/118818A1 |
The present invention refers to compounds of the formula (I) wherein X and R1 to R5 are defined as given in claim 1, as well as hair dye compositions containing them.
|
|
WO/2007/118964A1 |
The invention concerns polysubstituted N-(phenethyl)benzamide derivatives, pharmaceutical compositions containing same, as well as their therapeutic uses, in particular in the field of human and animal health. The invention also concerns...
|
|
WO/2007/118010A1 |
The present invention is directed (i) to a method for the preparation of a compound of formula (8) by condensing the compound of formula (7) with acetone and (ii) to a method for the preparation of a compound of formula (13) by alkylatin...
|
|
WO/2007/108204A1 |
A method of preparing an analysis sample which involves the sugar chain capture step comprising a reaction of capturing a sugar chain and/or a sugar derivative from a biological sample by using a sugar chain capture agent and the excisio...
|
|
WO/2007/109175A1 |
The invention relates to N-hydroxysulfonamide derivatives that donate nitroxyl (HNO) under physiological conditions and are useful in treating and/or preventing the onset and/or development of diseases or conditions that are responsive t...
|
|
WO/2007/106022A2 |
Novel crystal modifications of (5S)-5-[4-(5-chloro-pyridin-2-yloxy)-piperidine-1-sulfonylme
thyl]-5-methyl-imidazolidine-2,4-dione are disclosed together with processes for preparing such modifications, pharmaceutical compositions compri...
|
|
WO2007057756B1 |
The present invention relates to compounds of formula (I): wherein R1, R2, R4 and R4a are as defined herein. The invention also relates to the use of compounds of formula (I) for the treatment of pain.
|
|
WO/2007/099934A1 |
A combination of aliphatic amino acids labeled with stable isotope for realizing of an analysis of the conformation of protein of high molecular weight, especially molecular weight as high as exceeding 60 kDa. There is provided a combina...
|
|
WO/2007/095760A1 |
The invention includes novel compounds, including but not limited to formula A and formula B, and an improved delivery method. These compounds and methods are useful in preventing or treating diseases or conditions associated with or cau...
|
|
WO/2007/096034A1 |
A process for preparing 3,4-disubstituted phenylacetic acids of the formula (I) in which X is fluorine, chlorine, bromine or iodine and R is C1-C4-alkylthio, C1-C4-alkylsulfonyl or C1-C4-alkylsulfoxide, starting from a 2-halo-C1-C4-alkyl...
|
|
WO/2007/094664A1 |
The present invention relates to high refractive index monomers according to formula (I) and (co)polymers comprising such high refractive index monomers. The 5 (co)polymers are highly suitable for the manufacture of optical articles, in ...
|
|
WO/2007/093772A1 |
The present invention relates to a method of making monomers of the formula X=C (H) -Y-S02-CH2-CH (R) -OH which comprises reacting a compound of the formula Q-Y-S02-CH2-CH (R) -OH with a vinyl-containing organometallic reagent comprising...
|
|
WO/2007/090434A1 |
The invention relates to compounds of the formula (I) in which A1, A2, R1, R2, R3, R4, R5 and X have the definition specified in the description, to processes and intermediates for preparing them and to their use for controlling pests.
|
|
WO/2007/087960A1 |
The invention relates to the use of salts of compounds of the formula (1) and amines of the formula (2), where: R1 is C1-C30-alkyl, C2-C30-alkenyl, C6-C30-aryl or C7-C30-alkylaryl, R2 is C1-C30-alkyl, C2-C30-alkenyl, C6-C30-aryl or C7-C3...
|
|
WO/2007/085514A2 |
Method for producing L-methionine, D-methionine and/or any mixture of L-methionine and D-homoserine, by chemical conversion of L-homoserine or D-homoserine or corresponding mixtures of L-homoserine and D-homoserine, without going through...
|
|
WO/2007/083843A1 |
Disclosed are an aromatic compound having a perfluoroalkyl group and a gelatinizing agent for organic liquids which is composed of such an aromatic compound. Only a small amount of this gelatinizing agent is capable of gelatinizing a lar...
|
|
WO/2007/079515A1 |
14-0-[(((C1.6)Alkoxy-(C1.6)alkyl)-phenylsulfanyl)-acetyl]-mu
tilins, 14-O-[(((C1-6)Mono- or dialkylamino-(C1.6)alkyl)-phenylsulfanyl)-acetyl]-mutilins, 14-O-[((Hydroxy-(C1-6)-alkyl)-phenylsulfanyl)-acetyl]-mutili
ns, 14-O-[((Formyl-(C0.5...
|
|
WO/2007/081261A1 |
The present invention relates to a hydroxy- sulphureous acid, to a method for preparation of the hydroxysulphureous acid and to products based on said hydroxysulphureous acid, to methods for preparation of said products and to use of sai...
|
|
WO/2007/077876A1 |
A compound represented by the formula (I) below is used as an active ingredient in a pharmaceutical product for treatment or prevention of infectious diseases caused by protozoa or bacterium. [Chemical formula 1] (I) In the general formu...
|
|
WO/2007/077357A2 |
The present invention relates to dispersions of mineral particles in a hydrophobic organic medium (organosols) which are stabilized with amphiphilic polymers comprising: - a polymer chain of hydrophobic nature, which has an affinity with...
|
|
WO/2007/075534A2 |
Conjugates of a GLP-I moiety may be covalently attached to one or more water-soluble polymers. For instance, a GLP-I polymer conjugate may include a GLP-I moiety releasably attached at its N-terminus to a water-soluble polymer. The GLP-I...
|
|
WO/2007/074782A1 |
Disclosed is a photocurable resin composition which is highly sensitive to ultraviolet light or visible light having a long wavelength, in particular a photocurable resin composition which is useful as a sealing agent. Specifically discl...
|
|
WO/2007/071766A2 |
Novel compounds of the general formula (I), the use of these compounds as phar- maceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The presen...
|
|
WO/2007/071766A1 |
Novel compounds of the general formula (I), the use of these compounds as phar- maceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The presen...
|
|
WO/2007/069020A2 |
Described herein are N-hydroxyamlde antibacterial compounds, methods for making the compounds, pharmaceutical compositions containing the compounds and methods of treating bacterial infections utilizing the compounds and pharmaceutical c...
|
|
WO/2007/068894A2 |
The invention relates to substituted diphenylethers, -amines, -sulfides, and -methanes as useful pharmaceutical compounds for treating respiratory- disorders, pharmaceutical compositions containing them, and processes for their preparation.
|
|
WO/2007/070238A2 |
The present invention generally relates to an improved process for preparing modafinil and analogs thereof. The process minimizes impurities and improves the overall yield by oxidizing a modafinil intermediate compound in a reaction mixt...
|
|
WO/2007/069712A1 |
Disclosed is a novel amine compound represented by the general formula (I) below, a pharmaceutically acceptable acid addition salt of the compound, or a hydrate or solvate of the compound or the salt, which is excellent in an immunosuppr...
|
|
WO/2007/067994A1 |
Disclosed herein are carbonyl compounds of having the structural formula: (I) or a salt, ester, or prodrug thereof, Methods and compositions are disclosed for treating disease states including, but not limited to cancers, autoimmune dise...
|
|
WO/2007/067993A1 |
Disclosed herein are compounds of formula I and methods used for treating disease states including, but not limited to cancers, autoimmune diseases, tissue damage, central nervous system disorders, neurodegenerative disorders, fibrosis, ...
|
|
WO/2007/061337A1 |
The invention relates to the field of pharmaceutical chemistry and medicine. It refers to a new water-soluble antiviral agent based on silver-cistine compound of the formula C6H19N4O6S2LiAg2 and to the method of preparing thereof. The cl...
|
|
WO/2007/060839A1 |
A compound given by the formula (I): has an excellent controlling activity against noxious arthropods.
|
|
WO/2007/052001A2 |
A process for the preparation of a compound of formula (I) in which Y is absent or represents methylene, and X is O or S which comprises reacting a compound of formula (II) with a compound of formula (III) in which Y is absent or represe...
|
|
WO/2007/051995A2 |
A tert-butylammonium salt or an adamantylammonium salt of a compound of formula I wherein n is 0, 1 or 2 and R1 represents halo, a C1-4alkyl group which is optionally substituted by one or more fluoro, a C1-4alkoxy group which is optiona...
|
|
WO/2007/052329A1 |
Pentaerythritol which contains none of the alkali metals and alkaline earth metals or which contains at least one of these in a total amount of 1.0 wt.% or smaller is reacted with a mercaptocarboxylic acid to produce a pentaerythritol me...
|
|
WO/2007/049728A1 |
Since an amide compound represented by the formula (1) is effectiveness for controlling plant diseases, it is useful as an effective ingredient of a composition for controlling plant diseases.
|
|
WO/2007/048787A1 |
The invention relates to novel compounds of formula (I): H2N-CH(R1)-CH2-S-S- CH2-CH(R2)-CONH-R5, wherein R1 is a hydrocarbon chain, phenyl or benzyl radical, methylene radical substituted by a 5 or 6 atom heterocycle; R2 is a phenyl or b...
|
|
WO/2007/047305A1 |
The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal depositi...
|
|
WO/2007/046513A2 |
The present invention relates to a benzoylurea compound represented by formula (I), wherein X and Y represent a fluorine atom or a chlorine atom, R1 represents a lower alkyl group or the like, R2 represents a lower alkyl group, R3 repres...
|
|
WO/2007/042418A2 |
The instant invention discloses a process for preventing contact discoloration of substrates coming into contact with elastomers and stabilizing elastomers to prevent oxidative, thermal, dynamic, light-induced and/or ozone-induced degrad...
|
|
WO/2007/039555A1 |
Oximether compounds of formula (I) wherein A is selected from A1 and A2; E is O or S(=O)r; r is 0, 1 or 2; X is C-Y or N; Y is halogen, CN, NO2, NH2, OH, SH, R1, OR1, SR1, S(=O)R1, S(=O)2R1, NHR1, NR1R2, C(=O)H, C(=O)R1, C(=O)OH, C(=O)OR...
|
|
WO/2007/034924A1 |
Disclosed is a metallo-β-lactamase inhibitor which can inactivate a β-lactam antibiotic and recover the anti-bacterial activity of the β-lactam antibiotic. A maleic acid derivative having a structure of the general formula (I) has an ...
|
|
WO/2007/034064A1 |
The invention relates to a method for the continuous preparation of an α-amino acid having general formula (I) from the corresponding cyanhydrin of α-amino acid having general formula (II), in which R and R', which may be identical or ...
|
|
WO/2007/034251A1 |
The present invention relates to the CCR3 receptor ligands of the general formula (I), within them favourably to antagonists and to the salts, solvates and isomers thereof, to the pharmaceutical compositions containing them, to the use o...
|
|
WO/2007/034818A1 |
A treatment for paper, containing (A) a fluorine-containing polymer comprising repeating units derived from a fluorine-containing monomer (a) represented by the general formula (I): CH2=C(-X)-C(=O)-Y-(CH2)m-Z-(CH2)n-Rf (I) wherein X is h...
|
|
WO/2007/034254A2 |
The present invention relates to the CCR3 receptor ligands of the general formula (I), within them favourably to antagonists and to the salts, solvates and isomers thereof, to the pharmaceutical compositions containing them, to the use o...
|
|
WO/2007/034755A1 |
Compounds exerting high activities against various destructive insects and/or mites in agricultural and horticultural field, particularly excellent miticidal activity against Panonychus citri which is a weighty pest to citrus fruits, nam...
|
|
WO/2007/032177A1 |
A process for producing 4-(methylthio)butane-1,2-diol characterized by reacting 3-butene-1,2-diol with methanethiol in the presence of a carboxylic acid compound and at least one nitrogenous compound selected from the group consisting of...
|
|
WO/2007/033231A2 |
The present invention is directed to a novel lysine salts, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by PPAR delta. The present invention is further directed to a nov...
|
|
WO/2007/029036A2 |
The present invention relates to compounds of formula (I): or pharmaceutically acceptable salts or stereoisomers thereof. The compounds of the present invention are inhibitors of histone deacetylase (HDAC) and are useful for treating cel...
|
